Published in Emerg Infect Dis on January 01, 2008
Dengue and chikungunya in India. CMAJ (2009) 0.75
An overview on Sardinia's soft ticks (Ixodida: Argasidae). Exp Appl Acarol (2016) 0.75
Chikungunya, an epidemic arbovirosis. Lancet Infect Dis (2007) 7.87
Chikungunya outbreaks--the globalization of vectorborne diseases. N Engl J Med (2007) 6.05
The Newala epidemic. III. The virus: isolation, pathogenic properties and relationship to the epidemic. J Hyg (Lond) (1956) 4.63
Chikungunya outbreaks caused by African genotype, India. Emerg Infect Dis (2006) 3.97
Novel chikungunya virus variant in travelers returning from Indian Ocean islands. Emerg Infect Dis (2006) 3.43
Severe dengue virus infection in travelers: risk factors and laboratory indicators. J Infect Dis (2007) 2.92
Chikungunya fever. Lancet (2006) 1.97
Outbreak news. Chikungunya and dengue, south-west Indian Ocean. Wkly Epidemiol Rec (2006) 1.45
Probable dengue virus infection among Italian troops, East Timor, 1999-2000. Emerg Infect Dis (2003) 0.92
An autochthonous case of Zika due to possible sexual transmission, Florence, Italy, 2014. Euro Surveill (2016) 2.79
Emergence of Toscana virus in Europe. Emerg Infect Dis (2005) 2.70
Molecular epidemiology: HIV-1 and HCV sequences from Libyan outbreak. Nature (2006) 2.61
Precision and accuracy of a procedure for detecting recent human immunodeficiency virus infections by calculating the antibody avidity index by an automated immunoassay-based method. J Clin Microbiol (2002) 2.11
Imported Chikungunya Infection, Italy. Emerg Infect Dis (2007) 2.08
Chikungunya virus in North-Eastern Italy: a seroprevalence survey. Am J Trop Med Hyg (2010) 1.94
Spread of hepatitis C virus among European injection drug users infected with HIV: a phylogenetic analysis. J Infect Dis (2004) 1.85
The preoperative manometric pattern predicts the outcome of surgical treatment for esophageal achalasia. J Gastrointest Surg (2010) 1.83
Tularemia outbreak investigation in Kosovo: case control and environmental studies. Emerg Infect Dis (2002) 1.82
Changes over calendar time in the risk of specific first AIDS-defining events following HIV seroconversion, adjusting for competing risks. Int J Epidemiol (2002) 1.79
Hepatitis B immune memory in children primed with hexavalent vaccines and given monovalent booster vaccines: an open-label, randomised, controlled, multicentre study. Lancet Infect Dis (2010) 1.74
Identifying recent HIV infections using the avidity index and an automated enzyme immunoassay. J Acquir Immune Defic Syndr (2003) 1.74
Use of pegylated interferons is associated with an increased incidence of infections during combination treatment of chronic hepatitis C: a side effect of pegylation? Antivir Ther (2004) 1.65
Objective follow-up after laparoscopic repair of large type III hiatal hernia. Assessment of safety and durability. World J Surg (2007) 1.62
HIV protease inhibitors are potent anti-angiogenic molecules and promote regression of Kaposi sarcoma. Nat Med (2002) 1.59
Assessment of measles incidence, measles-related complications and hospitalisations during an outbreak in a southern Italian region. Vaccine (2005) 1.55
Point-of-care screening, prevalence, and risk factors for hepatitis B infection among 3,728 mainly undocumented migrants from non-EU countries in northern Italy. J Travel Med (2014) 1.54
Kaposi's sarcoma in transplant and HIV-infected patients: an epidemiologic study in Italy and France. Transplantation (2005) 1.52
Human herpesvirus 8 epidemiology: what we do and do not know. AIDS (2003) 1.49
Transmission of hemagglutinin D222G mutant strain of pandemic (H1N1) 2009 virus. Emerg Infect Dis (2010) 1.47
Etiology, diagnosis, and treatment of failures after laparoscopic Heller myotomy for achalasia. Ann Surg (2002) 1.45
Temporal trends in postseroconversion CD4 cell count and HIV load: the Concerted Action on Seroconversion to AIDS and Death in Europe Collaboration, 1985-2002. J Infect Dis (2007) 1.44
Unusual presentation of life-threatening Toscana virus meningoencephalitis. Clin Infect Dis (2004) 1.42
Risk of cancer following immunosuppression in organ transplant recipients and in HIV-positive individuals in southern Europe. Eur J Cancer (2007) 1.40
Role of individual's T-cell immunome in controlling HIV-1 progression. Immunology (2014) 1.39
The impact of transmitted drug resistance on the natural history of HIV infection and response to first-line therapy. AIDS (2006) 1.37
Current immunization policies for pneumococcal, meningococcal C, varicella and rotavirus vaccinations in Italy. Health Policy (2011) 1.34
Four hundred laparoscopic myotomies for esophageal achalasia: a single centre experience. Ann Surg (2008) 1.34
Effect of maternal HIV and malaria infection on pregnancy and perinatal outcome in Zimbabwe. J Acquir Immune Defic Syndr (2003) 1.33
High-resolution molecular epidemiology and evolutionary history of HIV-1 subtypes in Albania. PLoS One (2008) 1.30
A novel methodology for large-scale phylogeny partition. Nat Commun (2011) 1.29
TP53 codon 72 polymorphism and cervical cancer: a pooled analysis of individual data from 49 studies. Lancet Oncol (2009) 1.26
High sequence conservation of human immunodeficiency virus type 1 reverse transcriptase under drug pressure despite the continuous appearance of mutations. J Virol (2005) 1.24
The presence of anti-Tat antibodies is predictive of long-term nonprogression to AIDS or severe immunodeficiency: findings in a cohort of HIV-1 seroconverters. J Infect Dis (2005) 1.23
Risk factors for classical Kaposi's sarcoma. J Natl Cancer Inst (2002) 1.18
The novel KI, WU, MC polyomaviruses: possible human pathogens? New Microbiol (2011) 1.16
Incidence of AIDS-defining cancers after AIDS diagnosis among people with AIDS in Italy, 1986-1998. J Acquir Immune Defic Syndr (2003) 1.15
Epidemiology and costs of herpes zoster: background data to estimate the impact of vaccination. Vaccine (2007) 1.14
Specific antibodies reacting with simian virus 40 capsid protein mimotopes in serum samples from healthy blood donors. Hum Immunol (2012) 1.13
Primary human herpesvirus 8 infection in immunocompetent children. JAMA (2002) 1.13
Population dynamics of HIV-1 subtype B in a cohort of men-having-sex-with-men in Rome, Italy. J Acquir Immune Defic Syndr (2010) 1.12
Experimental studies of susceptibility of Italian Aedes albopictus to Zika virus. Euro Surveill (2016) 1.12
Dengue and chikungunya: long-distance spread and outbreaks in naïve areas. Pathog Glob Health (2014) 1.11
Excretion of the novel polyomaviruses KI and WU in the stool of patients with hematological disorders. J Med Virol (2009) 1.11
Detection of Toscana virus central nervous system infections in Sardinia Island, Italy. J Clin Virol (2007) 1.10
Role of beauty treatment in the spread of parenterally transmitted hepatitis viruses in Italy. J Med Virol (2004) 1.10
Human infection with highly pathogenic A(H7N7) avian influenza virus, Italy, 2013. Emerg Infect Dis (2014) 1.09
Hepatitis A incidence and hospital-based seroprevalence in Italy: a nation-wide study. Eur J Epidemiol (2007) 1.07
Changes over time in post-seroconversion CD4 cell counts in the Italian HIV-Seroconversion Study: 1985-2002. AIDS (2005) 1.07
The HIV type 1 epidemic in Bulgaria involves multiple subtypes and is sustained by continuous viral inflow from West and East European countries. AIDS Res Hum Retroviruses (2008) 1.07
Severe acute respiratory syndrome coronavirus sequence characteristics and evolutionary rate estimate from maximum likelihood analysis. J Virol (2004) 1.07
Ten years of Hib vaccination in Italy: prevalence of non-encapsulated Haemophilus influenzae among invasive isolates and the possible impact on antibiotic resistance. Vaccine (2011) 1.06
Epidemiological network analysis in HIV-1 B infected patients diagnosed in Italy between 2000 and 2008. Infect Genet Evol (2011) 1.04
Louseborne Relapsing Fever in Young Migrants, Sicily, Italy, July-September 2015. Emerg Infect Dis (2016) 1.04
Epidemiological history and phylogeography of West Nile virus lineage 2. Infect Genet Evol (2013) 1.03
Crimean-Congo hemorrhagic fever, southwestern Bulgaria. Emerg Infect Dis (2009) 1.03
Progress in Italy in control and elimination of measles and congenital rubella. Vaccine (2007) 1.02
Origin, evolution, and phylogeography of recent epidemic CHIKV strains. Infect Genet Evol (2012) 1.02
Decline of CD4⁺ T-cell count before start of therapy and immunological response to treatment in antiretroviral-naive individuals. AIDS (2011) 1.01
SARS epidemic in the press. Emerg Infect Dis (2004) 1.01
NK cell activity controls human herpesvirus 8 latent infection and is restored upon highly active antiretroviral therapy in AIDS patients with regressing Kaposi's sarcoma. Eur J Immunol (2002) 1.01
Lessons learnt from pandemic A(H1N1) 2009 influenza vaccination. Highlights of a European workshop in Brussels (22 March 2010). Vaccine (2010) 1.01
Long-term protection against SHIV89.6P replication in HIV-1 Tat vaccinated cynomolgus monkeys. Vaccine (2004) 1.01
Viral causes of influenza-like illness: Insight from a study during the winters 2004-2007. J Med Virol (2009) 1.00
Phylogeography and epidemiological history of West Nile virus genotype 1a in Europe and the Mediterranean basin. Infect Genet Evol (2011) 1.00
Estimated imported infections of Chikungunya and Dengue in Italy, 2008 to 2011. J Travel Med (2012) 0.99
An outbreak of hepatitis A virus infection with a high case-fatality rate among injecting drug users. J Hepatol (2005) 0.99
Continued high prevalence of HIV, HBV and HCV among injecting and noninjecting drug users in Italy. Ann Ist Super Sanita (2010) 0.99
Detection of recent HIV infections in African individuals infected by HIV-1 non-B subtypes using HIV antibody avidity. J Clin Virol (2008) 0.99
Chikungunya and the nervous system: what we do and do not know. Rev Med Virol (2009) 0.98
Identification of Merkel cell polyomavirus in the lower respiratory tract of Italian patients. J Med Virol (2010) 0.98
An outbreak of Q fever in Bulgaria. Ann Ist Super Sanita (2009) 0.98
Characterization of drug-resistance mutations in HIV type 1 isolates from drug-naive and ARV-treated patients in Bulgaria. AIDS Res Hum Retroviruses (2008) 0.98
High prevalence of serum antibodies reacting with simian virus 40 capsid protein mimotopes in patients affected by malignant pleural mesothelioma. Proc Natl Acad Sci U S A (2012) 0.98
Variation in adult vaccination policies across Europe: an overview from VENICE network on vaccine recommendations, funding and coverage. Vaccine (2012) 0.98
Protective efficacy of a multicomponent vector vaccine in cynomolgus monkeys after intrarectal simian immunodeficiency virus challenge. J Gen Virol (2004) 0.96
Genetic variability of the M genome segment of clinical and environmental Toscana virus strains. J Gen Virol (2007) 0.96
Humoral immunity in natural infection by tick-borne encephalitis virus. J Med Virol (2009) 0.95